Safety and Tolerability of Cael-101 in Combination with Anti-Plasma Cell Dyscrasia Therapy in Patients with AL Amyloidosis: 1-Year Results from an Open-Label Phase 2 Trial
Valent, Jason, Zonder, Jeffrey A., Liedtke, Michaela, Silowsky, John, Kurman, Michael R., Daniel, Eileen, Jobes, Janet, Harnett, Mark, Raviwong, Jessica, Spector, Michael, Sobolov, Susan B.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Cardiac Amyloid Reaching for Extended Survival (CARES): Study Design of Two Placebo-Controlled, Double-Blind, Randomized, International Phase 3 Trials Assessing Cael-101 in Patients with Mayo Stage Iiia or Stage IIIb AL Amyloidosis
Wechalekar, Ashutosh D., Silowsky, John, Daniel, Eileen, Harnett, Mark, Spector, Michael, Sobolov, Susan B., Quarta, Candida Cristina, Kurman, Michael R., Tulchinskiy, Mark, Bhattacharyya, Amit, Liedtke, Michaela
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Cael-101 Is Well-Tolerated in AL Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (CyborD): A Phase 2 Dose-Finding Study (NCT04304144)
Valent, Jason, Silowsky, John, Kurman, Michael R., Daniel, Eileen, Jobes, Janet, Harnett, Mark, Ziola, Margaret, Roviwong, Jessica, Fada, Sherry, Spector, Michael, Sobolov, Susan B.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
SAFETY AND TOLERABILITY OF CAEL-101, AN ANTI-AMYLOID MONOCLONAL ANTIBODY, IN COMBINATION WITH PLASMA CELL DYSCRASIA THERAPY IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS: RESULTS FROM A PHASE 2 STUDY
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey, Silowsky, John, Kurman, Michael, Daniel, Eileen, Jobes, Janet, Harnett, Mark, Bhattacharyya, Amit, Quarta, Candida Cristina, Catini, Julia, Raviwong, Jessica, Spector, Michael, Sobolov, Susan
Published in Journal of the American College of Cardiology (01.03.2022)
Published in Journal of the American College of Cardiology (01.03.2022)
Get full text
Journal Article
Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy
Valent, Jason, Silowsky, John, Kurman, Michael R., Daniel, Eileen, Jobes, Janet, Harnett, Mark, Fada, Sherry, Spector, Michael, Stefunek, Kathleen, Staley, Heather, Schlueter, Kristen, Samaras, Christy J., Anwer, Faiz, Khouri, Jack, Zonder, Jeffrey A., Liedtke, Michaela, Sobolov, Susan B.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Safety, Tolerability and Efficacy of Cael-101 in AL Amyloidosis Patients Treated on a Phase 2, Open-Label, Dose Selection Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis
Khouri, Jack, Anwer, Faiz, Samaras, Christy J., Mejia Garcia, Alex V., Koc, Omer N., Faiman, Beth M., Hamilton, Kimberly, Mathur, Saveta, Scott, Cynthia, Stefunek, Kathleen, Sgobbo, Josephine, Fada, Sherry, Lewis, Brittany, Shepherd, Kelly, Ahmad, Naqib, Knebusch, Madeleine, Sobolov, Susan B., Jobes, Janet, Daniel, Eileen, Spector, Michael, Valent, Jason
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Relationships between expectancies and adolescent dieting behaviors
Allen, Karen M., Thombs, Dennis L., Mahoney, Colleen A., Daniel, Eileen L.
Published in The Journal of school health (01.04.1993)
Published in The Journal of school health (01.04.1993)
Get full text
Journal Article